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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. In the present study, we evaluated the relationships of estimated
desaturase activities with cardiometabolic risk factors including
abdominal obesity, atherogenic lipoprotein phenotype and
inflammation in Koreans. Ninety three healthy volunteers partici 
pated in this cross sectional study. LDL particle size was determined
using gradient gel electrophoresis and inflammatory markers
including C reactive protein, soluble intercellular adhesion molecule 
1, and adiponectin were measured. Stearoyl–coA desaturase,
delta 6 desaturase and delta 5 desaturase were estimated as pre 
cursor to fatty acid ratios. The results showed that stearoyl–coA
desaturase was correlated with body mass index (r = 0.235,
p<0.05), triglyceride (r = 0.261,  p<0.001), and HDL cholesterol
(r = −0.226, p<0.05). Stearoyl–coA desaturase was associated with
only triglyceride (r = 0.283,  p<0.01). Delta 6 desaturase was
correlated with body mass index (r = 0.236,  p<0.05), waist
circumference (r = 0.218, p<0.05), triglyceride (r = 0.399, p<0.001),
C reactive protein (r = 0.333, p<0.001), soluble intercellular adhesion
molecule 1 (r = 0.229, p<0.05), HDL cholesterol (r = −0.325, p<0.01),
LDL particle size (r = −0.297, p<0.01) and adiponectin (r = −0.233,
p<0.05). In contrast, delta 5 desaturase was correlated with body
mass index (r = −0.324,  p<0.01), waist circumference (r = −0.276,
p<0.01), triglyceride (r = −0.329,  p<0.01), C reactive protein
(r = −0.215,  p<0.05), HDL cholesterol (r = 0.262,  p<0.05) and LDL
particle size (r = 0.278,  p<0.01). Stepwise multiple regression
analysis revealed that delta 6 desaturase (p<0.01) together with
waist circumference (p<0.001) were found to be independent
factors for determining plasma levels of C reactive protein (R2 =
0.230). Estimated desaturase activities are closely associated with
the features of cardiometabolic risk in Koreans.
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Introduction The concept of cardiometabolic risk factors is a cluster of
conventional cardiovascular risk factors and metabolic
syndrome factors including central obesity, hypertension, insulin
resistance, dyslipidemia, and inflammatory responses,(1) which are
known to increase cardiovascular morbidity. It has been demon-
strated that early detection and control of cardiometabolic risk
factors effectively reduce cardiovascular disease (CVD).(2–3)
Therefore, clinical settings require identifying potential biomarkers
to serve as noninvasive and sensitive predictors for the early stage
CVD and new markers for the cardiometabolic phenotype clusters.
Accumulating data have demonstrated that estimates of fatty
acid desaturases along with individual serum fatty acids are
related to CVD and predict risks and mortality of CVD.(4) Fatty
acid desaturase is the enzyme that catalyzes an endogenous fatty
acid synthesis. Desaturase activity is estimated indirectly as a
product/precursor fatty acid ratio in serum phospholipid or
cholesterol esters which reflects both dietary fatty acids intake and
endogenous metabolism of fatty acids.(5) Evidence from observa-
tional, case-control and prospective studies has shown that
desaturase avtivities are associated with CVD, obesity, insulin
resistance and metabolic syndrome.(6–8)
Based on the above information, evaluating the relationships
between estimated desaturase activities and comprehensive
cardiometabolic risk factors that are emerging risk factors for
CVD is clinically relevant, but it has not been extensively studied.
In the present study, we examined the associations between
estimated desaturase activities and individual fatty acid profiles
with cardiometabolic risk factors including abdominal obesity,
atherogenic lipoprotein phenotype and inflammation in Koreans.
For the measurements of cardiometabolic risks, we determined
body mass index (BMI) and waist circumference as surrogate
measures for abdominal obesity. Also, serum levels of triglyceride
(TG), HDL-cholesterol and LDL particle size were measured to
evaluate atherogenic dyslipidemia. And finally, plasma levels of
adiponectin, C-reactive protein (CRP) and soluble intercellular
adhesion molecule-1 (sICAM-1) were determined as markers for
inflammation.
Methods
Study subjects. Ninety-three volunteers participated in the
present study. The subjects were all healthy and those who were
taking hypolipidemic medication, antioxidative vitamins, or had
been diagnosed with uncontrolled hypertension or type 2 diabetes
mellitus were excluded. The purpose of the study was carefully
explained to all participants and their informed consent was
obtained prior to their participation. The study protocol was
approved by the Institutional Review Board of Yonsei University
College of Medicine and carried out in accordance with the Helsinki
Declaration.
Body weight and height were measured and BMI was calculated.
Waist circumference was measured twice to the nearest 0.1 cm
with a flexible tape measure at the level of the minimum circum-
ference, usually at the level of the navel. Venous blood samples
were collected from the forearm in EDTA-treated and plain tubes
after a fasting period. The tubes were immediately covered with
aluminum foil and placed on ice until they arrived at the analytical




Serum lipid profiles and LDL particle size. Fasting blood
samples were taken and serum cholesterol, LDL-cholesterol and
HDL-cholesterol were measured with commercially available
kits (Choongwae, Seoul, Korea) by enzymatic methods. Serum
triglyceride levels were analyzed using a total glycerol test kit
(Roche, Basel, Switzerland). All determinations were performed
on a Hitachi 747 auto-analyzer (Hitachi Ltd. Tokyo, Japan). Non-
denaturing polyacrylamide gradient gel electrophoresis with lipid
staining of the plasma was performed to determine peak LDL
particle diameter, as described previously.(9) Within this procedure,
a smaller LDL peak diameter indicates a relative abundance of
small, dense LDL particles.
Plasma CRP, sICAM 1 and adiponectin concentrations.
Plasma CRP was measured by an Express Plus autoanalyzer
(Chiron Diagnostics Co., MA) using a commercially available
high-sensitivity kit, CRP-Latex (II) X2 (Seiken Laboratories Ltd.,
Tokyo, Japan). Plasma levels of sICAM-1 were measured by
enzyme immunoassay (ELISA Kit, R&D Systems, Minneapolis,
MN). The resultant color reaction was read at 450 nm using a
Victor2 reader. Plasma adiponectin concentration was measured
using an enzyme immunoassay (Human Adiponectin ELISA kit,
B-Bridge International Inc., CA). The assay was read using a
Victor2 (Perkin Elmer Life Sciences, Turku, Finland) at 450 nm
and the wavelength correction was set to 540 nm.
Serum phospholipid fatty acid composition and estimation
of desaturase activity. Total lipids were extracted according
to the method of Folch, and the phospholipid fraction was isolated
by using thin-layer chromatography with hexane:diethyl ether:acetic
acid (80:20:2) development solvent. The phospholipid fractions
were then directly transesterified to prepare fatty acid methyl
esters (FAMEs) by the method of Lepage and Roy.(10) The FAME
of individual fatty acids of phospholipids were separated on a gas
chromatograph (model 6890, Agilent Technologies Inc., Palo
Alto, CA) equipped with a capillary column (OmegawaxTM 250;
30 m, Supelco, Bellefonte, PA) as previously described.(11) Peak
retention times were identified by comparison with known
standards (37 component FAME mix and PUFA-2, Supelco,
Bellefonte, PA; GLC37, NuCheck Prep, Elysian, MN) and
analyzed with ChemStation software (Agilent Technologies).
Serum phospholipid fatty acids were expressed as the percentage
of total fatty acids. The desaturase activities were calculated as
product/precursor ratios of individual fatty acids in serum phopho-
lipids. In this study, desaturase activities were estimated as follows:
stearoyl–coA desaturase (SCD) 16 = 16:1n-7/16:0, SCD18 =
18:1n-9/18:0, delta-6 desaturase (D6D) = 20:3n-6/18:2n-6, delta-5
desaturase (D5D) = 20:4n-6/20:3n-6.(4,8,12–13)
Statistical analysis. The SPSS 12.0 software package was
used for statistical analysis. Data are presented as the means ±
SD Each variable was examined for normal distribution, and
abnormally distributed variables were log-transformed. Pearson
correlation coefficients were used to evaluate correlations between
variables. Stepwise multiple regression analysis was performed to
determine the contributing factors to plasma levels of CRP. p
values less than 0.05 were considered statistically significant.
Results
Age, gender, anthropometrics and biochemical measurements
of total subjects were presented in Table 1. This study consisted
of 93 subjects with a mean age of 54.4 ± 12.6 years (36 males and
57 females). All were healthy and their mean BMI was 23.3 ±
2.7 kg/m2.
Serum phospholipid fatty acid composition in total sub 
jects. Table 2 shows the relative contents (%) of several
individual fatty acids in serum phospholipids. Desaturase activities
estimated by fatty acid product-to-precursor ratios are also shown
in Table 2.
Correlation analysis between fatty acids/estimated
desaturase activities and cardiometabolic risks. As shown
in Table 3, palmitoleic acid was positively correlated with BMI
(r = 0.250, p<0.05) and serum levels of TG (r = 0.310, p<0.01)
and negatively correlated with serum levels of HDL-cholesterol
(r = −0.222, p<0.05) and LDL particle size (r = −0.245, p<0.05),
while oleic acid was positively correlated with serum levels of TG
(r = 0.318, p<0.01). Also, the proportion of linoleic acid (LA) was
negatively related to waist circumference (r = −0.280, p<0.01),
serum levels of TG (r = −0.238, p<0.05), and CRP (r = −0.230,
p<0.05) and positively related to LDL particle size (r = 0.305,
Table 1. Age, gender, anthropometrics and biochemical measurements
in total subjects
mean ± SD.
Total subjects (n =9 3 )
Age (years) 54.4 ± 13.4
Gender (M:F) 36:57
BMI (kg/m2) 23.3 ± 2.7
Waist circumferences (cm) 78.5 ± 7.5
Triglyceride (mg/dL) 161.0 ± 134.1
Total cholesterol (mg/dL) 194.2 ± 38.9
LDL cholesterol (mg/dL) 126.8 ± 35.7
HDL cholesterol (mg/dL) 51.5 ± 12.9
LDL particle size (nm) 26.2 ± 1.9
C reactive protein (mg/dL) 0.94 ± 1.63
Adiponectin (μg/dL) 7.4 ± 3.5
sICAM 1(ng/dL) 628.3 ± 152.2
Table 2. Proportions of fatty acid composition in serum phospholipids
and estimated desaurase activities in total subjects
mean ± SD. Expressed as percentage of total fatty acids.
Total subjects (n =9 3 )
12:0 lauric acid 0.15 ± 0.1
14:0 myristic acid 0.68 ± 0.16
16:0 palmitic acid 27.9 ± 2.41
16:1 palmitoleic acid 0.77 ± 0.23
18:0 stearic acid 14.99 ± 1.52
18:1 ω9 oleic acid 7.87 ± 1.16
18:1t ω9 elaidic acid 2.3 ± 0.47
18:2 ω6 linoleic acid  14.7 ± 2.22
18:2 tt linolelaidic acid 0.76 ± 1.94
18:3 ω6 γ linolenic acid 0.2 ± 0.14
18:3 ω3 α linolenic acid 0.55 ± 0.32
20:0 arachidic acid 0.99 ± 0.37
20:1 ω9 gondoic acid (cis 11 eicosenoic acid) 0.4 ± 0.23
20:2 cis 11,14 eicosadienoic acid 1.32 ± 0.42
20:3 ω6 dihimo r linolenic acid 2.64 ± 0.66
20:3 ω3 5 8 11 eicosatrienoic acid 0.51 ± 0.33
20:4 ω6 arachidonic acid 6.52 ± 1.37
20:5 ω3 EPA 2.68 ± 0.9
22:0 behenic acid 1.89 ± 0.43
22:1 erucic acid 0.52 ± 0.23
22:2 docosadienoic acid 0.25 ± 0.22
24:0 lignoceric acid 1.91 ± 0.5
22:6 ω3 DHA 8.2 ± 1.71
SCD16 (16:1n 7/16:0) 0.028 ± 0.008
SCD18 (18:1n 9/18:0) 0.529 ± 0.084
D6D (20:3n 6/18:2n 6) 0.185 ± 0.059
D5D (20:4n 6/20:3n 6) 2.58 ± 0.7 J. Clin. Biochem. Nutr. | September 2011 | vol. 49 | no. 2 | 133
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p<0.01) and plasma levels of adiponectin (r = 0.262,  p<0.05).
Furthermore, the proportion of dihomo-r-linolenic acid (DHLA)
was significantly associated with serum levels of TG (r = 0.383,
p<0.001), HDL-cholesterol (r = −0.335, p<0.001), CRP (r = 0.278,
p<0.01) and LDL particle size (r = −0.218, p<0.05). On the other
hand, eicosapentaenoic acid (EPA) was negatively associated
with plasma levels of adiponectin (r = −0.322, p<0.01).
Table 4 presents the correlates between estimated desaturase
activities and cardiometabolic risks in total subjects. Specifically,
SCD16 was positively correlated with BMI (r = 0.235, p<0.05),
and serum levels of TG (r = 0.261,  p<0.001), and negatively
correlated with serum levels of HDL-cholesterol (r = −0.226,
p<0.05). Also, a high degree of SCD16 tended to show reduced
LDL particle size, which did not reach statistical significance
(r = −0.189, p = 0.07). On the other hand, SCD18 was positively
associated with only serum levels of TG (r = 0.283, p<0.01). D6D
was positively correlated with BMI (r = 0.236,  p<0.05), waist
circumference (r = 0.218, p<0.05), serum levels of TG (r = 0.399,
p<0.001), CRP (r = 0.333,  p<0.001), and sICAM-1 (r = 0.229,
p<0.05) and negatively correlated with serum levels of HDL-
cholesterol (r = −0.325, p<0.01), LDL particle size (r = −0.297,
p<0.01) and plasma levels of adiponectin (r = −0.233, p<0.05). In
contrast, D5D was negatively correlated with BMI (r = −0.324,
p<0.01), waist circumference (r = −0.276, p<0.01), serum levels
of TG (r = −0.329, p<0.01) and CRP (r = −0.215, p<0.05) and
positively correlated with serum levels of HDL-cholesterol
(r = 0.262, p<0.05) and LDL particle size (r = 0.278, p<0.01).
Stepwise multiple regression analysis to identify factors
affecting plasma CRP levels. Stepwise multiple regression
analysis was performed to identify factors influencing CRP, a
surrogate marker for systemic inflammation. The independent
variables include baseline characteristics such as age, gender,
BMI, waist circumference, alcohol intake, smoking and exercise,
serum levels of TG and HDL-cholesterol and estimated desaturase
index. The results show that D6D (p<0.01) together with waist
circumference (p<0.001) were found to be independent factors for
determining plasma levels of CRP (R2 = 0.230, Table 5).
Discussion
In the present study, we comprehensively examined the relation-
ships of estimated desaturase activities and individual serum fatty
acids with cardiometabolic risk factors in Koreans. This cross-
sectional study showed that not only palmitoleic acid, LA and
DHLA but also desaturases such as SCD16, SCD18, D6D and
D5D were closely related to cardiometabolic risk factors. In
addition, D6D was found to be an independent factor for deter-
mining CRP which is a surrogate marker for low grade chronic
inflammation.
A number of clinical studies have reported that individual
Table 3. Correlation analysis between serum phospholipid fatty acids and cardiometabolic risks
*p<0.05, **<0.01, ***<0.001.
BMI waist TG HDL c LDL particle size CRP Adiponectin sICAM 1
12:0 –0.026 –0.071 –0.14 –0.06 –0.064 –0.084 0.045 0.057
14:0 –0.202 –0.136 –0.152 –0.048 –0.033 –0.028 0.2 –0.085
16:0 0.079 0.104 0.193 0.001 –0.202 –0.044 0.013 –0.016
16:1 0.250* 0.159 0.310** –0.222* –0.245* 0.072 –0.066 0.125
18:0 0.015 0.069 0.04 –0.041 –0.07 0.005 0.067 0.058
18:1 ω9 –0.048 –0.037 0.318** 0.067 –0.197 –0.128 –0.022 –0.062
18:1t ω9 –0.017 –0.014 –0.311** 0.053 0.116 0.031 0.187 0.169
18:2 –0.174 –0.280** –0.238* 0.163 0.305** –0.230* 0.262* –0.221
18:2 tt 0.036 0.099 0.078 –0.149 –0.102 0.039 0.081 0.029
18:3 ω6 0.081 –0.02 0.074 –0.02 0.115 0.073 –0.023 0.007
18:3 ω3 –0.032 –0.136 –0.017 0.038 0.155 0.112 –0.028 –0.104
20:0 0.055 0.093 –0.189 0.04 0.146 0.148 0.106 0.109
20:1 ω9 –0.091 0.131 0.054 0.008 –0.071 0.038 –0.104 0.186
20:2 0.137 0.076 –0.179 –0.024 0.038 0.02 0.084 0.056
20:3 ω6 0.192 0.136 0.383*** –0.335*** –0.218* 0.278** –0.179 0.135
20:3 ω3 0.109 0.133 0.121 0.005 –0.008 0.178 –0.165 0.145
20:4 ω6 –0.194 –0.204 –0.016 0.02 0.14 0.051 –0.154 –0.066
20:5 ω3 0.189 0.168 0.116 –0.02 –0.167 0.206 –0.332** 0.018
22:0 0.012 0.127 –0.288** 0.026 0.067 0.026 0.103 0.187
22:1 –0.049 –0.004 –0.104 0.017 0.006 0.249* –0.076 0.034
22:2 –0.086 –0.107 –0.185 0.161 0.278** 0.036 0.087 –0.045
24:0 0.033 0.096 –0.321** 0.048 0.148 0.051 0.154 0.205
22:6 ω3 –0.001 0.02 –0.06 –0.021 0.051 0.011 –0.173 –0.046
Table 4. Correlates between estimated desaturase activity and cardiometabolic risks in total subjects
*p<0.05, **<0.01, ***<0.001. D5D: delta 5 desaturase. D6D: delta 6 desaturase. SCD: stearoyl–CoA desaturase.
BMI Waist  TG HDL c LDL particle size CRP Adiponectin sICAM 1
SCD16 0.235* 0.125 0.261** –0.226* –0.189 0.087 –0.07 0.127
SCD18 –0.05 –0.07 0.283** 0.087 –0.16 –0.115 –0.061 –0.087
D6D 0.236* 0.218* 0.399*** –0.325** –0.297** 0.333*** –0.233* 0.229*
D5D –0.324** –0.276** –0.329** 0.262* 0.278** –0.215* 0.045 –0.187doi: 10.3164/jcbn.10 147
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serum fatty acids were related to CVD and predicted risk and
mortality of CVD. Specifically, proportions of LA(14) and palmitic
acid(4,15) were related to CVD, and low serum proportions of LA
could predict myocardial infarction over 19 years and were corre-
lated with a high rate of CVD mortality.(4,16) The mechanism by
which serum fatty acids are associated with CVD has not been
fully elucidated, but is possibly mediated by their involvement in
blood cholesterol concentrations, insulin resistance, inflammation
and endothelial function.(17–20) Indeed, it was reported in a Spanish
study(21) that LA and n-3 fatty acid were inversely related to CRP
levels and α-linolenic acid and EPA were inversely associated
with CRP in a French study.(22) There is also evidence that DHLA
is related to insulin resistance and obesity(23–24) through the in-
creased activity of D6D in response to lower intake of 18:2 n-6,
which can further contribute to CVD. Similar to previous studies,
our results show that palmitoleic acid was positively correlated
with BMI and serum levels of TG and negatively correlated with
serum levels of HDL-cholesterol and LDL particle size, while
oleic acid was positively correlated with serum levels of TG. In
addition, the proportion of LA was negatively related to waist
circumference, serum levels of TG, and CRP and positively related
to LDL particle size and plasma levels of adiponectin. Furthermore,
the proportion of DHLA was significantly associated with serum
levels of TG, HDL-cholesterol, CRP and LDL particle size. These
data support that fatty acid profiles as reflected by dietary intakes
may affect the cardiometabolic risks, which may be a potential
mechanism explaining the residual cardiovascular risks beyond
LDL-cholesterol levels.
Of interest is the observation that the proportions of EPA
were negatively associated with plasma levels of adiponectin.
Adiponectin is an important mediator linking obesity and cardio-
vascular disease through various mechanisms including anti-
atherogenic and anti-inflammatory effects.(25) Regarding the
stimulating effect of EPA on adipoectin secretion in adipocytes,
previous experimental studies have shown conflicting data. It
was reported that EPA and docosahexaenoic acid (DHA) may
upregulate adiponectin by acting as ligands of peroxisome
proliferator-activated receptor-γ (PPARγ),(26) the transcriptional
regulator interacting directly with adiponectin promoters. In
contrast, others have reported that EPA significantly decreased
adiponectin gene expression and protein secretion and reduced
PPARγ mRNA levels in adipocytes, suggesting that this impair-
ment in PPARγ could explain, at least in part, the decrease in
adiponectin gene expression and protein secretion induced by EPA
treatment.(27) Further studies to elucidate the underlying mecha-
nism for the stimulation of adiponectin by fatty acids are warranted.
With respect to the associations of desaturase activities and
CVD, high SCD and D6D are generally known to have adverse
effects on metabolic and CVD risk factors, while high D5D acts
favorably.(4,6,13,28) For example, SCD18 was positively associated
with BMI, blood pressure, total and LDL-cholesterol and nega-
tively associated with HDL-cholesterol.(13) Cross-sectional research
in adolescents demonstrated that D6D was positively correlated
with most of the CVD risk factors but D5D was inversely correlated
with TG and insulin.(8) There is also evidence that that low D5D
can be related to the development of coronary heart disease and it
may predict metabolic syndrome and cardiovascular mortality.(4,16,29)
In the present study, consistent with the earlier results, SCD16 was
associated with abdominal obesity as measured by BMI and
atherogenic lipoprotein phenotype such as TG and HDL-
cholesterol, while SCD18 was positively associated with only
serum levels of TG. In addition, D6D was favorably associated
with a constellation of cardiometabolic risk factors. In contrast,
D5D was unfavorably associated with a cluster of cardiometabolic
risk factors. Moreover, D6D along with waist circumference were
found to be independent factors for CRP, suggesting that D6D
among desaturase activities may be the most useful predictor for
cardiometabolic risks. CRP is a marker of systemic low-grade
inflammation with high sensitivity and is an independent factor for
coronary vascular disease.(30) Therefore, it is possible that D6D
can contribute to chronic diseases by involving inflammatory
responses. This study also provides additional information on their
relationships to LDL particle size, which is known to be a pre-
dictor of CVD development.(31–32)
Remarkably, an important finding in our study is that D6D
showed a positive association with sICAM-1, an endothelium
derived proinflammatory cytokine and a negative association
with adiponectin which has an anti-inflammatory property. The
potential mechanism linking D6D to inflammation is that the long
chain polyunsaturated fatty acids (PUFAs) synthesized by D6D
may affect the permeability and function of cell membranes,(33)
and furthermore, they can be used as ligands for transcriptional
factors(34–35) that are responsible for inflammatory pathways. Alter-
natively, PUFAs synthesized by D6D participate in synthesizing
eicosanoids(36) which act as inflammatory mediators. Considering
that average dietary fat intake is relatively low in the background
diet of Koreans, the quantity and quality of endogenously synthe-
sized fat by desaturases can be important in modulating inflam-
matory pathways.
Taken together, the metabolic effects mediated by desaturases
are so profound that they can influence obesity, atherogenic
lipoprotein phenotype and proinflammatory responses, a cardio-
metabolic phenotype cluster. There are some limitations of this
study as follows. We demonstrated that D6D had close associa-
tions with cardiometabolic risk factors but could not prove the
cause or result, since this is a cross-sectional study and a small
sample size makes it difficult to generalize the results. Thus, a
prospective study with a large sample size is needed to confirm
our data. Finally, there is no data on dietary fatty acids, so we
cannot identify relationships between dietary fatty acids and
serum fatty acids. Despite these limitations, this is the first study to
evaluate associations between various desaturase activities along
with serum individual fatty acids and overall cardiometabolic risks
in Koreans. In conclusion, estimated desaturase activities are
closely associated with the features of cardiometabolic risks in
Koreans, raising the possibility that such activities might be
effective biomarkers for the prediction of cardiovascular and
metabolic diseases.
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Table 5. Stepwise multiple regression analysis to identify factors influencing C reactive protein levels







p value R2 p value
β coefficients
CRP
Waist circumference 0.355 <0.001
0.23 <0.001
D6D 0.255 <0.01 J. Clin. Biochem. Nutr. | September 2011 | vol. 49 | no. 2 | 135
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Abbreviations





D5D delta 5 desaturase
D6D delta 6 desaturase
EPA eicosapentaenoic acid
FAME fatty acid methyl ester
LA linoleic acid
PPAR peroxisome proliferator-activated receptor
PUFAs polyunsaturated fatty acids
SCD stearoyl–CoA desaturase
sICAM-1 soluble intercellular adhesion molecule-1
TG triglyceride
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